These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31803025)

  • 1. Identification of KCC2 Mutations in Human Epilepsy Suggests Strategies for Therapeutic Transporter Modulation.
    Duy PQ; David WB; Kahle KT
    Front Cell Neurosci; 2019; 13():515. PubMed ID: 31803025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal K
    McMoneagle E; Zhou J; Zhang S; Huang W; Josiah SS; Ding K; Wang Y; Zhang J
    Acta Pharmacol Sin; 2024 Jan; 45(1):1-22. PubMed ID: 37704745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Efficacy of the KCC2 Cotransporter Promotes Epileptic Oscillations in a Subiculum Network Model.
    Buchin A; Chizhov A; Huberfeld G; Miles R; Gutkin BS
    J Neurosci; 2016 Nov; 36(46):11619-11633. PubMed ID: 27852771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical insights into therapeutic targeting of KCC2 for disorders of neuronal hyperexcitability.
    Duy PQ; He M; He Z; Kahle KT
    Expert Opin Ther Targets; 2020 Jul; 24(7):629-637. PubMed ID: 32336175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The KCC2 Cotransporter and Human Epilepsy: Getting Excited About Inhibition.
    Kahle KT; Khanna AR; Duan J; Staley KJ; Delpire E; Poduri A
    Neuroscientist; 2016 Dec; 22(6):555-562. PubMed ID: 27130838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic potential of human SLC12A5 variants causing KCC2 dysfunction.
    Fukuda A; Watanabe M
    Brain Res; 2019 May; 1710():1-7. PubMed ID: 30576625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seizing Control of KCC2: A New Therapeutic Target for Epilepsy.
    Moore YE; Kelley MR; Brandon NJ; Deeb TZ; Moss SJ
    Trends Neurosci; 2017 Sep; 40(9):555-571. PubMed ID: 28803659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The suppressive effect of the specific KCC2 modulator CLP290 on seizure in mice.
    Cai J; Wu Z; Wang G; Zhao X; Wang X; Wang BH; Yu J; Liu X; Wang Y
    Epilepsy Res; 2024 Jul; 203():107365. PubMed ID: 38677001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current view on the functional regulation of the neuronal K(+)-Cl(-) cotransporter KCC2.
    Medina I; Friedel P; Rivera C; Kahle KT; Kourdougli N; Uvarov P; Pellegrino C
    Front Cell Neurosci; 2014; 8():27. PubMed ID: 24567703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinase-KCC2 coupling: Cl- rheostasis, disease susceptibility, therapeutic target.
    Kahle KT; Delpire E
    J Neurophysiol; 2016 Jan; 115(1):8-18. PubMed ID: 26510764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel pathogenic
    Järvelä V; Hamze M; Komulainen-Ebrahim J; Rahikkala E; Piispala J; Kallio M; Kangas SM; Nickl T; Huttula M; Hinttala R; Uusimaa J; Medina I; Immonen EV
    Front Mol Neurosci; 2024; 17():1372662. PubMed ID: 38660387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Mechanisms of Epilepsy: The Role of the Chloride Transporter KCC2.
    Belperio G; Corso C; Duarte CB; Mele M
    J Mol Neurosci; 2022 Jul; 72(7):1500-1515. PubMed ID: 35819636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crossing the Chloride Channel: The Current and Potential Therapeutic Value of the Neuronal K
    Tillman L; Zhang J
    Biomed Res Int; 2019; 2019():8941046. PubMed ID: 31240228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neto2-null mice have impaired GABAergic inhibition and are susceptible to seizures.
    Mahadevan V; Dargaei Z; Ivakine EA; Hartmann AM; Ng D; Chevrier J; Ormond J; Nothwang HG; McInnes RR; Woodin MA
    Front Cell Neurosci; 2015; 9():368. PubMed ID: 26441539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seizures regulate the cation-Cl
    Bonet-Fernández JM; Tranque P; Aroca-Aguilar JD; Muñoz LJ; López DE; Escribano J; de Cabo C
    Front Neurol; 2023; 14():1207616. PubMed ID: 37448751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenuous Inhibitory GABAergic Signaling in the Reticular Thalamus.
    Klein PM; Lu AC; Harper ME; McKown HM; Morgan JD; Beenhakker MP
    J Neurosci; 2018 Jan; 38(5):1232-1248. PubMed ID: 29273603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A noninvasive optical approach for assessing chloride extrusion activity of the K-Cl cotransporter KCC2 in neuronal cells.
    Ludwig A; Rivera C; Uvarov P
    BMC Neurosci; 2017 Jan; 18(1):23. PubMed ID: 28143398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired neuronal KCC2 function by biallelic SLC12A5 mutations in migrating focal seizures and severe developmental delay.
    Saitsu H; Watanabe M; Akita T; Ohba C; Sugai K; Ong WP; Shiraishi H; Yuasa S; Matsumoto H; Beng KT; Saitoh S; Miyatake S; Nakashima M; Miyake N; Kato M; Fukuda A; Matsumoto N
    Sci Rep; 2016 Jul; 6():30072. PubMed ID: 27436767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionotropic and metabotropic kainate receptor signalling regulates Cl
    Garand D; Mahadevan V; Woodin MA
    J Physiol; 2019 Mar; 597(6):1677-1690. PubMed ID: 30570751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compromising KCC2 transporter activity enhances the development of continuous seizure activity.
    Kelley MR; Deeb TZ; Brandon NJ; Dunlop J; Davies PA; Moss SJ
    Neuropharmacology; 2016 Sep; 108():103-10. PubMed ID: 27108931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.